Grove Bank & Trust Novo Nordisk A S Transaction History
Grove Bank & Trust
- $739 Million
- Q1 2025
A detailed history of Grove Bank & Trust transactions in Novo Nordisk A S stock. As of the latest transaction made, Grove Bank & Trust holds 2,164 shares of NVO stock, worth $151,090. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,164
Previous 13,131
83.52%
Holding current value
$151,090
Previous $1.13 Million
86.71%
% of portfolio
0.02%
Previous 0.16%
Shares
9 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.31 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.03 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$865 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$860 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$829 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $158B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...